As President Trump addressed a joint session of Congress tonight, reporters from across NPR's newsroom fact-checked his ...

As President Trump addresses a joint session of Congress tonight, reporters from across NPR's newsroom will fact check and ...

This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...

We can now prevent HIV transmissions and deaths — progress impossible without investments from the U.S. government ...

Pepfar, a global initiative to fight HIV/Aids, has saved millions of lives since its launch in 2003. Now its future is ...

The possibility of ending the HIV epidemic in Europe is more tangible than ever, but the actions we take now will determine ...

| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...

Clinical Trial Reveals Twice-Yearly Injection to Be 96% Effective in HIV Prevention Nov. 27, 2024 — Recent results from a recent clinical trial indicate that a twice-yearly injection of ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding promises. It's a good economic investment, says the Fund's Peter Sands, into a ...

The US halts funding for African health programs, threatening HIV progress, vaccine trials, and thousands of healthcare jobs.